Protein produced by nervous system may be the key to treating inflammatory diseases

A Rutgers-led team may have found the key to treating inflammatory diseases like asthma, allergies, chronic fibrosis and chronic obstructive pulmonary disease (COPD).

In a study published in the journal Nature Immunology, researchers discovered that neuromedin B (NMB), a protein produced by the nervous system, was responsible for preventing overactive immune responses and damaging inflammation.

An immune response refers to the body's ability to recognize and defend itself against harmful substances. Although beneficial to help clear infections, an immune response can also promote damaging inflammation if not properly restricted.

The researchers found that the NMB protein can stop the type of inflammation that that occurs in diseases like asthma, allergies, chronic fibrosis and COPD.

"For many years, the mechanism through which the body shuts down an inflammatory response to heal itself after worm infections remained poorly understood," said Mark C. Siracusa, lead author and an assistant professor at the Rutgers New Jersey Medical School.

"Our study provided that understanding and a hope for possible treatments using NMB, which has great potential to treat inflammatory diseases like asthma, allergies and COPD."

COPD is the third most common cause of death among inflammatory diseases and allergies the sixth in the United States.

Scientists previously thought the immune system was capable of regulating itself in order to resolve inflammation to prevent tissue damage. However, emerging work is beginning to reveal that complex interactions between the immune system and the nervous system serve to restrict inflammation and promote health."

Mark C Siracusa, Study Lead Author and Assistant Professor, New Jersey Medical School, Rutgers University

A patent cooperation treaty (PCT) patent application was filed by Rutgers Office of Research Commercialization. The next steps for researchers include developing drugs using the protein to treat diseases like asthma, COPD, and allergies.

Source:
Journal reference:

Inclan-Rico, J. M., et al. (2020) Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition. Nature Immunology. doi.org/10.1038/s41590-020-0753-y.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rutgers University. (2022, December 19). Protein produced by nervous system may be the key to treating inflammatory diseases. AZoLifeSciences. Retrieved on December 23, 2024 from https://www.azolifesciences.com/news/20200818/Protein-produced-by-nervous-system-may-be-the-key-to-treating-inflammatory-diseases.aspx.

  • MLA

    Rutgers University. "Protein produced by nervous system may be the key to treating inflammatory diseases". AZoLifeSciences. 23 December 2024. <https://www.azolifesciences.com/news/20200818/Protein-produced-by-nervous-system-may-be-the-key-to-treating-inflammatory-diseases.aspx>.

  • Chicago

    Rutgers University. "Protein produced by nervous system may be the key to treating inflammatory diseases". AZoLifeSciences. https://www.azolifesciences.com/news/20200818/Protein-produced-by-nervous-system-may-be-the-key-to-treating-inflammatory-diseases.aspx. (accessed December 23, 2024).

  • Harvard

    Rutgers University. 2022. Protein produced by nervous system may be the key to treating inflammatory diseases. AZoLifeSciences, viewed 23 December 2024, https://www.azolifesciences.com/news/20200818/Protein-produced-by-nervous-system-may-be-the-key-to-treating-inflammatory-diseases.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Analyzing and acknowledging HIV protein may result in new treatments, study reveals